» Articles » PMID: 35367363

Multifunctional Role of Exosomes in Viral Diseases: From Transmission to Diagnosis and Therapy

Overview
Journal Cell Signal
Date 2022 Apr 3
PMID 35367363
Authors
Affiliations
Soon will be listed here.
Abstract

Efforts to discover antiviral drugs and diagnostic platforms have intensified to an unprecedented level since the outbreak of COVID-19. Nano-sized endosomal vesicles called exosomes have gained considerable attention from researchers due to their role in intracellular communication to regulate the biological activity of target cells through cargo proteins, nucleic acids, and lipids. According to recent studies, exosomes play a vital role in viral diseases including covid-19, with their interaction with the host immune system opening the door to effective antiviral treatments. Utilizing the intrinsic nature of exosomes, it is imperative to elucidate how exosomes exert their effect on the immune system or boost viral infectivity. Exosome biogenesis machinery is hijacked by viruses to initiate replication, spread infection, and evade the immune response. Exosomes, however, also participate in protective mechanisms by triggering the innate immune system. Besides that, exosomes released from the cells can carry a robust amount of information about the diseased state, serving as a potential biomarker for detecting viral diseases. This review describes how exosomes increase virus infectivity, act as immunomodulators, and function as a potential drug delivery carrier and diagnostic biomarker for diseases caused by HIV, Hepatitis, Ebola, and Epstein-Barr viruses. Furthermore, the review analyzes various applications of exosomes within the context of COVID-19, including its management.

Citing Articles

Exosome Revolution or Marketing Mirage? AI-Based Multi-domain Evaluation of Claims, Scientific Evidence, Transparency, Public Sentiment, and Media Narratives.

Rahman E, Sayed K, Rao P, Abu-Farsakh H, Sadeghi-Esfahlani S, Garcia P Aesthetic Plast Surg. 2025; .

PMID: 40055226 DOI: 10.1007/s00266-025-04712-3.


A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.

Ebrahimi F, Modaresi Movahedi A, Sabbaghian M, Poortahmasebi V Health Sci Rep. 2024; 7(11):e70196.

PMID: 39558933 PMC: 11570872. DOI: 10.1002/hsr2.70196.


Cell-cell communication: new insights and clinical implications.

Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J Signal Transduct Target Ther. 2024; 9(1):196.

PMID: 39107318 PMC: 11382761. DOI: 10.1038/s41392-024-01888-z.


Research progress on the mechanism of exosome-mediated virus infection.

Zhang H, Liu X, Shi J, Su X, Xie J, Meng Q Front Cell Infect Microbiol. 2024; 14:1418168.

PMID: 38988816 PMC: 11233549. DOI: 10.3389/fcimb.2024.1418168.


Exosome for mRNA delivery: strategies and therapeutic applications.

Iqbal Z, Rehman K, Mahmood A, Shabbir M, Liang Y, Duan L J Nanobiotechnology. 2024; 22(1):395.

PMID: 38965553 PMC: 11225225. DOI: 10.1186/s12951-024-02634-x.


References
1.
Harding C, Heuser J, Stahl P . Exosomes: looking back three decades and into the future. J Cell Biol. 2013; 200(4):367-71. PMC: 3575527. DOI: 10.1083/jcb.201212113. View

2.
Shen K, Jia Y, Wang X, Zhang J, Liu K, Wang J . Exosomes from adipose-derived stem cells alleviate the inflammation and oxidative stress via regulating Nrf2/HO-1 axis in macrophages. Free Radic Biol Med. 2021; 165:54-66. DOI: 10.1016/j.freeradbiomed.2021.01.023. View

3.
Takahashi K, Yan I, Wood J, Haga H, Patel T . Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res. 2014; 12(10):1377-87. PMC: 4201956. DOI: 10.1158/1541-7786.MCR-13-0636. View

4.
Huang I, Bailey C, Weyer J, Radoshitzky S, Becker M, Chiang J . Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011; 7(1):e1001258. PMC: 3017121. DOI: 10.1371/journal.ppat.1001258. View

5.
Rosell A, Havervall S, von Meijenfeldt F, Hisada Y, Aguilera K, Grover S . Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Arterioscler Thromb Vasc Biol. 2020; 41(2):878-882. PMC: 7837685. DOI: 10.1161/ATVBAHA.120.315547. View